SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001615774-17-004282
Filing Date
2017-08-11
Accepted
2017-08-11 16:37:06
Documents
7
Effectiveness Date
2017-08-11

Document Format Files

Seq Description Document Type Size
1 S-8 s107150_s8.htm S-8 400684
2 EXHIBIT 5.1 s107150_ex5-1.htm EX-5.1 6393
3 EXHIBIT 23.1 s107150_ex23-1.htm EX-23.1 2213
4 GRAPHIC pg1img1_s8.jpg GRAPHIC 10094
5 GRAPHIC pg39img1_s8.jpg GRAPHIC 13392
6 GRAPHIC pg1img1_ex5-1.jpg GRAPHIC 19008
7 GRAPHIC pg1img2_ex5-1.jpg GRAPHIC 12958
  Complete submission text file 0001615774-17-004282.txt   487317
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-219928 | Film No.: 171025627
SIC: 2834 Pharmaceutical Preparations